医学
葡萄膜炎
斯科普斯
入射(几何)
梅德林
眼科
验光服务
皮肤病科
法学
政治学
物理
光学
作者
Genevieve F. Oliver,Roy M. Stathis,Nicola Spurrier,Justine R. Smith
出处
期刊:Ophthalmology
[Elsevier]
日期:2017-03-31
卷期号:124 (7): 1084-1085
被引量:5
标识
DOI:10.1016/j.ophtha.2017.03.009
摘要
Uveitis is a heterogeneous group of infectious and noninfectious intraocular inflammatory diseases. Management of both subsets of uveitis is frequently challenging. 1 de Smet M.D. Taylor S.R. Bodaghi B. et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011; 30: 452-470 Crossref PubMed Scopus (221) Google Scholar Since 2000, advances in microbial diagnostics and introduction of biologic drugs, combined with the potential for electronic communication to facilitate research on diseases with low incidence, have provided uveitis specialists with unprecedented opportunities for clinical trials to establish evidence-based management algorithms. Hampering this effort, however, was lack of a common system for describing uveitis, including diagnosis, severity, and outcome. 2 Rosenbaum J.T. Holland G.N. Uveitis and the Tower of Babel. Arch Ophthalmol. 1996; 114: 604-605 Crossref PubMed Scopus (16) Google Scholar
科研通智能强力驱动
Strongly Powered by AbleSci AI